Biosimilar showdown: CHS-1420 vs humira in healthy adults
NCT ID NCT07147257
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 16 times
Summary
This study checked whether a new medicine called CHS-1420 behaves like the approved drug Humira in the body. It involved 238 healthy Chinese adults who received a single dose of either drug. The goal was not to treat any disease, but to see if the two drugs are similar enough for further testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ethics Committee of Hopeshine-Minsheng Hospital of Xinzheng
Zhengzhou, China
Conditions
Explore the condition pages connected to this study.